Factors Associated with HIV Status Disclosure and Its Effect on Treatment Adherence and Quality of Life among Children 6–17 Years on Antiretroviral Therapy in Southern Highlands Zone, Tanzania: Unmatched Case Control Study

Table 7

Crude and adjusted ratio for the association between HIV status disclosure and quality of life, among children between 6 and 17 years on ART, in Southern Highlands Zone, Tanzania (N = 309).

Variables	OR (95% CI)	P value	AOR (95% CI)	P value
HIV status disclosure:
No	Ref
Yes	3.203 (1.889, 5.432)	<0.001	3.283(1.791, 6.017)	<0.001
Age of the child:
6 to 9 years	Ref
10 to 13 years	2.165 (1.353, 3.464)	0.111	1.403 (0.709, 2.776)	0.331
14 to 17 years	2.060 (1.068, 3.971)	<0.05	1.513 (0.656, 3.485)	0.331
Sex of the child
Males	Ref
Females	1.451 (0.920, 2.289)	0.110	1.602 (0.978, 2.625)	0.061
Child/caregiver relationships:
Biological parent(s)	Ref
Others	1.796 (1.114, 2.888)	0.016	0.500 (0.300, 0.834)	<0.05
ART adherence:
No	Ref
Yes	1.569 (0.619, 3.978)	0.343	1.567 (0.578, 4.249)	0.378